These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24005067)

  • 41. [Pathogenesis, clinical aspects and development of fatty liver].
    Eitel B; Kleine FD; Kleine S
    Dtsch Z Verdau Stoffwechselkr; 1985; 45(3):111-6. PubMed ID: 4042954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The natural history of non-alcoholic fatty liver disease.
    Caldwell S; Argo C
    Dig Dis; 2010; 28(1):162-8. PubMed ID: 20460906
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The role of ultrasonography in the diagnosis of diffuse liver disease].
    Berrut C; Curati W; de Gautard R; Widmann JJ; Godin N; Loizeau E
    Schweiz Med Wochenschr; 1986 Feb; 116(7):215-8. PubMed ID: 3513304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology.
    Skelly MM; James PD; Ryder SD
    J Hepatol; 2001 Aug; 35(2):195-9. PubMed ID: 11580141
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Management of non alcoholic fatty liver diseases in adults].
    Pariente A
    Rev Prat; 2012 Dec; 62(10):1421-5. PubMed ID: 23424926
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cryptogenic cirrhosis and NAFLD: are they related?
    Maheshwari A; Thuluvath PJ
    Am J Gastroenterol; 2006 Mar; 101(3):664-8. PubMed ID: 16464222
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathological features of fatty liver disease.
    Yeh MM; Brunt EM
    Gastroenterology; 2014 Oct; 147(4):754-64. PubMed ID: 25109884
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Alcoholic and non-alcoholic steatohepatitis: who is affected and what can we do for them?].
    Gallego-Durán R; Ampuero J; Funuyet J; Romero-Gómez M
    Gastroenterol Hepatol; 2013 Nov; 36(9):587-96. PubMed ID: 24011648
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High prevalence of metabolic complications in patients with non-alcoholic fatty liver disease.
    Friis-Liby I; Aldenborg F; Jerlstad P; Rundström K; Björnsson E
    Scand J Gastroenterol; 2004 Sep; 39(9):864-9. PubMed ID: 15513385
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis.
    Itoh S; Yougel T; Kawagoe K
    Am J Gastroenterol; 1987 Jul; 82(7):650-4. PubMed ID: 3605026
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The prophylactic value of ambulatory liver biopsy].
    Frank H; Leodolter I
    Dtsch Z Verdau Stoffwechselkr; 1968; 28(5):313-6. PubMed ID: 5731585
    [No Abstract]   [Full Text] [Related]  

  • 52. The accuracy of ultrasound in the detection of fatty infiltration of the liver.
    Foster KJ; Dewbury KC; Griffith AH; Wright R
    Br J Radiol; 1980 May; 53(629):440-2. PubMed ID: 7388276
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fatty liver: how frequent is it and why?
    Bedogni G; Bellentani S
    Ann Hepatol; 2004; 3(2):63-5. PubMed ID: 15257248
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C.
    Saadoun D; Asselah T; Resche-Rigon M; Charlotte F; Bedossa P; Valla D; Piette JC; Marcellin P; Cacoub P
    Hepatology; 2006 Jun; 43(6):1337-45. PubMed ID: 16729318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Non-alcoholic fatty liver: position document of the Catalan Society of Gastroenterology].
    Caballería L; Saló J; Berzigotti A; Planas R; Vila C; Huertas C; Torres M; Torán P; Caballería J;
    Gastroenterol Hepatol; 2014; 37(6):372-83. PubMed ID: 24746904
    [No Abstract]   [Full Text] [Related]  

  • 56. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary.
    Farrell GC; Chitturi S; Lau GK; Sollano JD;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):775-7. PubMed ID: 17565629
    [No Abstract]   [Full Text] [Related]  

  • 57. [Acute hepatic steatosis. Description of a clinical case of sodium valproate-induced acute hepatic steatosis].
    Coraggio F; Angiulli B; Carbone M; Catalano A; Costa MR; Gargiulo L; Gentile B; Masetto O; Pomponio N; Scarpato P
    Clin Ter; 1988 Mar; 124(6):451-63. PubMed ID: 2974353
    [No Abstract]   [Full Text] [Related]  

  • 58. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee.
    Vajro P; Lenta S; Socha P; Dhawan A; McKiernan P; Baumann U; Durmaz O; Lacaille F; McLin V; Nobili V
    J Pediatr Gastroenterol Nutr; 2012 May; 54(5):700-13. PubMed ID: 22395188
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Percutaneous liver biopsy in diabetics--experiences between 1968 and 1971].
    Schmidt R; Tennstedt A
    Z Arztl Fortbild (Jena); 1974 Mar; 68(6):298-302. PubMed ID: 4418773
    [No Abstract]   [Full Text] [Related]  

  • 60. How should we manage patients with non-alcoholic fatty liver disease in 2007?
    Chan HL; de Silva HJ; Leung NW; Lim SG; Farrell GC;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):801-8. PubMed ID: 17565632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.